# The First Affiliated Hospital of Guangzhou Medical University: Phase 4 study in Pneumococcal Polysaccharide Vaccine, Influenza Vaccines (1278 participants)

**Score:** 40/100

| Field | Value |
|---|---|
| Sponsor | The First Affiliated Hospital of Guangzhou Medical University |
| Sponsor type | Academic and hospital |
| Study | Preoperative Pneumococcal and Influenza Vaccination to Prevent Postoperative Pulmonary Infection in Patients Undergoing Lung Resection for Pulmonary Nodules or Lung Cancer |
| NCT ID | NCT07885540 |
| Phase | Phase 4 |
| Status | not yet recruiting |
| Conditions | Pneumococcal Polysaccharide Vaccine; Influenza Vaccines; Preoperative; Lung Resection Surgery; Thoracic Surgery |
| Intervention types | biological |
| Target enrollment | 1278 |
| Posted | 2026-10-21 |
| Planned start | 2026-11-01 |
| Event | Newly registered study |
| Event date | 2026-10-21 |

## Why this score
- 1278 participants planned.
- Not yet recruiting: vendors still being chosen.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07885540). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.